Fingerlakes Wealth Management’s Pfizer PFE Stock Holding History

Fingerlakes Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,461	Closed	-$223K	–	88
2023 Q1	$223K	Buy	5,461 +54	+1%	+$2.33K	0.28%	84
2022 Q4	$277K	Sell	5,407 -232	-4%	-$11.1K	0.38%	75
2022 Q3	$247K	Sell	5,639 -594	-10%	-$28.9K	0.36%	70
2022 Q2	$327K	Buy	6,233 +49	+0.8%	+$2.5K	0.45%	66
2022 Q1	$320K	Buy	6,184 +51	+0.8%	+$2.65K	0.37%	70
2021 Q4	$361K	Buy	+6,133	New	+$304K	0.41%	64

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fingerlakes Wealth Management's PFE Position: Q2 2023 in Review

Fingerlakes Wealth Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,461 shares — an estimated $223K sold.

Fingerlakes Wealth Management first reported a position in PFE in Q4 2021 and held it in 6 quarters. The position peaked at $361K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Fingerlakes Wealth Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Fingerlakes Wealth Management sold 5,461 Pfizer shares in Q2 2023, an estimated $223K.
Fingerlakes Wealth Management first reported a position in Pfizer in Q4 2021 and held it in 6 quarters.
Fingerlakes Wealth Management's Pfizer position peaked at $361K in Q4 2021.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Fingerlakes Wealth Management's 13F filing for Q2 2023, filed 10 Aug 2023.